Literature DB >> 18076571

Putative tumor suppressor EDD interacts with and up-regulates APC.

Ryuichi Ohshima1, Tomohiko Ohta, Wenwen Wu, Ayaka Koike, Tsuguo Iwatani, Michelle Henderson, Colin K W Watts, Takehito Otsubo.   

Abstract

Adenomatous polyposis coli (APC), whose mutation causes colorectal cancers, is a key player in the Wnt signaling pathway. While the role of APC in inhibition of beta-catenin/LEF1-dependent activation of transformation-inducing genes has been intensively studied and well established, regulation of APC expression at the protein level is only partially understood. Here we report that APC is up-regulated by EDD, the mammalian orthologue of Drosophila melanogaster"hyperplastic discs" gene (hyd) that is considered to be a putative tumor suppressor. Screening of APC immunocomplexes by mass spectrometry identified EDD as a putative APC-interacting protein. Exogenously expressed and endogenous APC interacted with EDD in vivo. Indirect immunofluorescent analyses demonstrated that APC and EDD co-localized in the cytoplasm of the cell. Over-expression of EDD enhanced the protein expression level of APC and its binding partner Axin, resulting in inhibition of Wnt signaling downstream of beta-catenin. Conversely, siRNA knock-down of EDD down-regulated APC at the protein level without altering its mRNA level, causing enhanced protein expression of beta-catenin. Thus, through protein-protein interaction, EDD stabilizes APC and up-regulates APC's function to inhibit beta-catenin, suggesting that EDD could act as a colorectal tumor suppressor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18076571     DOI: 10.1111/j.1365-2443.2007.01138.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  15 in total

1.  A global genomic view on LNX siRNA-mediated cell cycle arrest.

Authors:  Dan Zheng; Shaohua Gu; Yao Li; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

Review 2.  The various roles of ubiquitin in Wnt pathway regulation.

Authors:  Daniele V F Tauriello; Madelon M Maurice
Journal:  Cell Cycle       Date:  2010-09-25       Impact factor: 4.534

3.  The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding.

Authors:  Juliana Muñoz-Escobar; Edna Matta-Camacho; Guennadi Kozlov; Kalle Gehring
Journal:  J Biol Chem       Date:  2015-07-29       Impact factor: 5.157

Review 4.  Physiological functions of the HECT family of ubiquitin ligases.

Authors:  Daniela Rotin; Sharad Kumar
Journal:  Nat Rev Mol Cell Biol       Date:  2009-05-13       Impact factor: 94.444

Review 5.  Wnt signaling from development to disease: insights from model systems.

Authors:  Ken M Cadigan; Mark Peifer
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-08       Impact factor: 10.005

6.  EDD inhibits ATM-mediated phosphorylation of p53.

Authors:  Shiyun Ling; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2011-03-07       Impact factor: 5.157

7.  Modulation of myocardin function by the ubiquitin E3 ligase UBR5.

Authors:  Guoqing Hu; Xiaobo Wang; Darren N Saunders; Michelle Henderson; Amanda J Russell; B Paul Herring; Jiliang Zhou
Journal:  J Biol Chem       Date:  2010-02-18       Impact factor: 5.157

8.  E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60.

Authors:  V K Subbaiah; Y Zhang; D Rajagopalan; L N Abdullah; N S L Yeo-Teh; V Tomaić; L Banks; M P Myers; E K Chow; S Jha
Journal:  Oncogene       Date:  2015-08-03       Impact factor: 9.867

Review 9.  Atypical ubiquitylation - the unexplored world of polyubiquitin beyond Lys48 and Lys63 linkages.

Authors:  Yogesh Kulathu; David Komander
Journal:  Nat Rev Mol Cell Biol       Date:  2012-07-23       Impact factor: 94.444

10.  The EDD E3 ubiquitin ligase ubiquitinates and up-regulates beta-catenin.

Authors:  Avital Hay-Koren; Michal Caspi; Alona Zilberberg; Rina Rosin-Arbesfeld
Journal:  Mol Biol Cell       Date:  2010-11-30       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.